Phase II study of everolimus and sorafenib for the treatment of metastatic thyroid cancer Meeting Abstract
| Authors: | Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Lipson, B. L.; Kurz, S.; Fagin, J. A.; Pfister, D. G. |
| Abstract Title: | Phase II study of everolimus and sorafenib for the treatment of metastatic thyroid cancer |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419602148 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.6024 |
| Notes: | Meeting Abstract: 6024 -- Source: Wos |
